NEW YORK (GenomeWeb) – CareDx today announced that its European distributor of AlloMap tests, Diaxonhit, has signed a service sub-licensing agreement with the Strasbourg University Hospitals to perform all AlloMap testing at a dedicated facility in Strasbourg, France.

Diaxonhit is the exclusive distributor of AlloMap in Europe. The blood-based molecular diagnostic test allows clinicians to monitor heart transplant recipients for acute cellular rejection.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.